Navigation Links
ViroPharma Launches Novel Campaign to Illustrate the Emotional Burden of Hereditary Angioedema
Date:12/12/2012

EXTON, Pa., Dec. 12, 2012 /PRNewswire/ -- ViroPharma Incorporated (NASDAQ: VPHM) today announced the launch of a new unbranded campaign focusing on moments lost to hereditary angioedema (HAE) attacks to raise awareness among physicians of the emotional and psychological burden of HAE on patients' lives. HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of a human plasma protein called C1 inhibitor. People living with HAE experience physical manifestations of attacks including, swelling and pain, but much of the true burden lies in the emotional and psychological implications for patients that greatly impact the quality of their life. Visit http://www.momentsmissed.com to find out more about the emotional burden of HAE.

HAE can have a tremendous impact on a patients' mental health, daily life, and future plans. HAE attacks are highly variable and unpredictable, and many people living with HAE experience multiple attacks per month. Many patients struggle with fear of the next attack, causing a devastating psychological impact including anxiety, depression, and isolation. Approximately 50 percent of patients experience a laryngeal attack, and nearly all live in fear of having such an attack.

"Through this campaign we hope to illustrate that HAE is not just an acute clinical condition, but can also be an emotional and psychological burden to patients," said Frank Nazzario, ViroPharma's associate director, marketing. "HAE is a life altering disease that interferes with work, school, travel and social life. ViroPharma created this campaign to give a voice to patients who bear the emotional burden of HAE and to raise awareness of the moments that are missed as a result of this disease."  

About Hereditary Angioedema (HAE)
HAE is a rare, severely debilitating, life-th
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
2. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
3. ViroPharma To Participate In The JMP Securities Healthcare Conference
4. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
5. ViroPharma To Release 2012 Second Quarter Financial Results On August 9, 2012
6. ViroPharma Incorporated Reports Second Quarter 2012 Financial Results
7. ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference
8. ViroPharma To Host Analyst And Investor Seminar On September 21, 2012
9. ViroPharma Incorporated Reports Third Quarter 2012 Financial Results
10. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
11. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014  Medical Science Liaisons serve as a ... the healthcare sector. As the impact of technology in ... how Medical Science Liaisons (MSLs) interact with physicians and ... the tablet to not only share important disease and ... thought leader interactions across geographies and therapeutic areas. ...
(Date:8/22/2014)... 22, 2014 ... has announced the addition of the  "Global ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... instrument for any modern science laboratory as ... materials. It can be broadly classified into ...
(Date:8/22/2014)... Research and Markets ( ... the  "Global Operating Room Equipment Market 2014-2018" ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,An operating room is ... a healthcare facility used to perform surgical ... equipment, which ensures patient care and enhanced ...
Breaking Medicine Technology:iPads Enhancing Medical Science Liaison Interactions with Thought Leaders, New Study Shows 2Global Laboratory Electronic Balance Market 2014-2018: Key Vendors are A&D Company, Mettler-Toledo, Sartorius and Thermo Fisher 2Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2
... June 13 Telmisartan, an angiotensin receptor blocker, ... been studied in clinical trials in more than 50,000 patients. ... market exposure of 34.5 million patient years. Convincing safety data ... the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which ...
... Scientists from the Barbara Ann Karmanos Cancer Institute in ... agents used to promote bone health and inhibit resorption, may ... early stage breast cancer who take them for their anti-osteoporosis ... Society of Clinical Oncology Annual Meeting. , ...
Cached Medicine Technology:Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010 2Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010 3Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010 4Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010 5Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer 2Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer 3Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer 4
(Date:8/22/2014)... Epidermal growth factor receptor (EGFR) mutations found in ... of advanced non-small cell lung cancer (NSCLC) patients correlates ... DNA. , EGFR tyrosine kinase inhibitor (TKI) therapy is ... NSCLC, but the standard for determining mutation status is ... be limited or not available. A more abundant and ...
(Date:8/22/2014)... DC (PRWEB) August 22, 2014 Paying ... little easier in the coming year for four nurse ... the National League for Nursing Foundation for Nursing ... – will share $28,000, $10,000 more than in 2013, ... Ann Kerr Endowment and Elizabeth Isaac Marcil Endowment Funds, ...
(Date:8/22/2014)... August 22, 2014 Advancements in ... some clinical applications due to their cost-effectiveness, non-invasiveness, ... innovations in ultrasound, such as the evolution of ... to keep the market moving throughout 2014 and ... can enhance not only the point-of-care (POC) testing ...
(Date:8/22/2014)... IL (PRWEB) August 22, 2014 Eagerly ... a thriving fertility destination, and now offers the top ... team of infertility specialists. The fertility network of ... overall commitment to world-class reproductive care, female and male ... lives up to the standards so eminently set by ...
(Date:8/22/2014)... County, NJ (PRWEB) August 22, 2014 ... a leading specialist in Internal Medicine, Geriatrics, Hospice ... the network, CarePoint Health Medical Group. Their system ... highly skilled and experienced physicians comprise CarePoint Health ... and practices in Hudson County, representing a wide ...
Breaking Medicine News(10 mins):Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:Dr. Reisner Joins CarePoint Health Medical Group 2
... 16 In this tough economy many,Americans are losing ... looking,at alternative health insurance options. Not only ... for most individuals and families, the loss of,health care ... the mortgage and,banking crisis, medical bills remain the leading ...
... Medical,International Limited (NYSE: MR ), a leading ... that it will present at,the 27th Annual J.P. Morgan ... The conference will ... Ronald Ede, Group Vice President of International,Operations and May ...
... can no longer be ignored. Treadmill desks offer a unique solution that ... ... America,s fixation on low carb diets has been shown to be ineffective ... it may have harmful effects on brain function as well. The study ...
... the unrivaled success of the diabetes pill DBCare®, Healing Power has ... alleviate physical and mental ailments such as blood pressure, allergies and ... ... December 16, 2008 - Healing Power Inc., a leader in all-natural ...
... large, multicenter clinical trial has shown that a diet ... in fat compared to standard federal dietary recommendations cuts ... breast cancer survivors women who didn,t have hot ... have higher recurrence and lower survival rates than breast ...
... Dec. 15 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... on, Tuesday, December 16, 2008, at 10:00 am (ET) ... the product profile, clinical and regulatory progress and the ... (DDS-04A), a serotonin antagonist reuptake inhibitor (SARI), for the ...
Cached Medicine News:Health News:HealthInsuranceFinders.com Publishes Health Insurance Guide for the Recently Unemployed 2Health News:HealthInsuranceFinders.com Publishes Health Insurance Guide for the Recently Unemployed 3Health News:HealthInsuranceFinders.com Publishes Health Insurance Guide for the Recently Unemployed 4Health News:Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Health News:Low Carb Diets Shown to Impair Cognitive Function, Treadmill Desks Improve It 2Health News:Low Carb Diets Shown to Impair Cognitive Function, Treadmill Desks Improve It 3Health News:Healing Power Inc. Introduces New Web Site with 14 New Ayurvedic Products to Promote a Healthier Life 2Health News:Healing Power Inc. Introduces New Web Site with 14 New Ayurvedic Products to Promote a Healthier Life 3Health News:Diet may cut risk of breast cancer recurrence in women without hot flashes 2Health News:Diet may cut risk of breast cancer recurrence in women without hot flashes 3Health News:Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET 2Health News:Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET 3Health News:Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET 4
... Crossover system of implants and instruments provides ... posterior rod construct in the thoracic and ... system are available in three size ranges: ... can be used with the Isola, Pediatric ...
Portable ultrasound doppler system for peripheral and transcranial investigation....
Multiwindow transcranial and peripheral Doppler system....
Bi-Directional doppler volume flowmeter....
Medicine Products: